Turner-Warwick, M., B. Burrows, and A. Johnson. 1980. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 35: 171-180.
Rudd, R. M., P. L. Haslam, and M. Turner-Warwick. Cryptogenic fibrosing alveolitis relationships of pulmonary physiology and bronchoalveolar lavage to treatment and prognosis. Am. Rev. Respir. Dis. 124: 1-8.
Johnston, I. D. A., R. J. Prescott, J. C. Chalmers, R. M. Rudd, and for the Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 52: 38-44.
Gay, S. E., et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am. J. Respir. Crit. Care Med. 157: 1063-1072.
Hubbard, R., I. Johnston, and J. Britton. Survival in patients with cryptogenic fibrosing alveolitis: A population-based cohort study. Chest 113: 396-400.
Joraker, J. A., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 157: 199-203.
Mapel, D. W., W. C. Hunt, R. Utton, K. B. Baumgartner, J. M. Samet, and D. B. Coultas. Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax 53: 469-476.